Figure 3. Nuclear translocation of IRS-1 in Medulloblastomas.
Immunohistochemistry for the IGF-IR/IR docking molecule, IRS-1, shows a prominent nuclear localization in clinical samples of medulloblastomas that express the JCV early oncoprotein, large T-antigen (upper panels). In T-antigen negative samples, IRS-1 remains in the cytoplasm of neoplastic cells (middle panels). In some tumors that lack T-antigen expression IRS-1 is still located to the nucleus in association with Estrogen Receptor beta (lower panels). Original magnification for all panels 600x.
